A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma.
暂无分享，去创建一个
T. Lister | R. Gupta | J. Radford | A. Rohatiner | C. Crawley | P. Johnson | J. Sweetenham | J. Foran | J. Matthews | S. Johnson | I. Micallef | K. Summers | Karin E. Summers | John Radford | Raj K. Gupta | J. Matthews | Ivana N. Micallef | Stephen A. Johnson | J. W. Sweetenham | John W. Sweetenham